One hundred and two patients undergoing elective abdominal aortic aneurysm repair and admitted to ICU at RPAH in 1989/90 were studied. In forty patients a cell saver was used during the operative procedure (Group CS) while in the remaining sixty-two patients intraoperative blood loss was drained and discarded conventionally (Group NCS). Preoperative ASA grade and postoperative APACHE score were similar in these two groups.
Elective abdominal aortic aneurysm repair is a procedure often involving significant blood loss. In a recent literature review, Hessel l found the average blood loss to be greater than two litres, requiring replacement with an average of 4.5 units of stored bank blood. In this review transfusion was a cause of morbidity in three per cent of patients.
The desire to avoid stressing already overextended blood banks and the possibility of transmitting serious disease have led us to look for ways of minimising or even avoiding blood transfusion. Moreover with any blood issued from a blood bank, the possibility of human error in checking and administering exists. Various techniques of autologous transfusion have been employed, including pre-donation and isovolaemic haemodilution prior to induction of anaesthesia. 2 The use ofpre-donation is, however, limited by patient and practitioner compliance and isovolaemic haemodilution can cause delays in theatre lists. An autologous scavenginglreinfusion system has been available at our centre since 1986. Initially it was acquired for liver transplantation, but with the advent of more technically compact systems it has gained wide acceptance in major vascular surgery.
This study was performed in order to show that the cell saver could safely reduce or even sometimes abolish the need for transfusion of bank blood in elective abdominal aortic aneurysm repair.
METHOD
All patients (n = 102) undergoing elective abdominal aortic aneurysm repair at Royal Prince Alfred Hospital between January 1989 and December 1990 were studied retrospectively.
The preoperative data recorded were age, sex, haemoglobin, plasma creatinine concentration and ASA classification. 3 Operative details noted were the surgeon in charge, estimated blood loss (as recorded on the anaesthetic chart), number of units of bank blood transfused and whether the cell saver was utilized (Group CS; n = 40) or not (Group NCS; n = 62). Vse of the cell saver depended upon the individual anaesthetist's and surgeon's preferences.
The cell saver used was the 'Electromedics AT 1000 Autotransfusion System with Pulse Wash' (Tuta Laboratories, Sydney, Australia) ( Figure I) . The collection capacity of the system was 3.0 litres with a 40 micron filtration capacity and defoaming capability. The surgical suckers may be powered by the inbuilt vacuum pump which can produce negative pressures of 0-300 mmHg, providing fluid flows of 0-1000 mllmin. However, we found these flows to be inadequate and the vacuum pump to be Blood is collected in the cardiotomy reservoir, from where it is pumped into the centrifuge for washing. The washed cells are pumped into the transfer bag in preparation for reinfusion. The system is closed and reinfusion is indirect (via the transfer bag), thus negating the risk of air embolus. rather noisy, so wall suction was applied to the reservoir. This adaptation produces a maximum negative pressure of about 450 mmHg which may generate fluid flows in the vicinity of 3000 mllmin. A safety release valve on the cardiotomy reservoir which opens at negative pressures in excess of 250 mmHg is however included to prevent excessive haemolysis of scavenged blood. The anticoagulant used was heparin (30,000 V/I 0.9% sodium chloride solution) which was titrated to blood collection flowrate by the operator (17 ml of heparinized saline per 100 ml of blood recommended by the manufacturer).
When sufficient blood has been collected in the cardiotomy reservoir, a unit can be processed. Clamp 3 opens while clamps I and 2 close ( Figure  I ) allowing blood to be aspirated into the centrifuge where it is spun down in preparation for washing. Clamp I opens as clamps 2 and 3 close, washing then takes place at a rate of one litre of normal saline to produce 225 ml of washed cells with an haematocrit of about 0.5. The washed cells are then pumped into the transfer bag as clamp 2 opens while clamps 1 and 3 close and the roller pump reverses flow.
Reinfusion was via a transfer bag, a closed system with air removed, to which a pump set was connected. A 14 gauge (SWG) cannula or 8 gauge (Fr) Swan Ganz introducer was routinely used in a peripheral vein, allowing fluid administration rates in the vicinity of 600 mllmin.
Thiopentone/relaxant/nitrous oxide/oxygen/ inhalational agent general anaesthesia was administered in every case. Some patients had intraoperative opioids and all patients had intravenous opioid administered (usually 0.3-0.6 mglkg of morphine) prior to transfer from theatres to ICV. No patients had an epidural inserted.
Postoperatively all patients were admitted to the Intensive Care Vnit. The length of stay in the ICV was noted, as were the initial postoperative haemoglobin and initial APACHE 2 score. 4 The highest postoperative creatinine and the total number of units of bank blood transfused during the admission were recorded.
Outcome (left hospital) of surgery was noted. Statistical analysis of data was performed using the Number Crunch er Statistical program. 5 Differences between groups were determined using the Student's t-test (P < 0.01 considered significant).
RESULTS
Preoperative details of the patients are shown in Table 1 . Sex distribution was similar in both groups. There were 11 women (28%) and 29 men (72%) in Group CS and 17 women (24%) and 45 men (76%) in Group NCS. The two groups were temporarily interdigitated; however, use of the cell saver increased throughout the study period from 15% of cases in the first year to 47% of cases in the second year. The operative, postoperative and total in-hospital administration of bank blood is shown in Table 2 .
Of Group CS, 22 patients (55%) were given no bank blood compared with two patients (3%) in Group NCS (Figure 2 ).
Seven surgeons (S I-S7) performed the operations. Details of the estimated blo~d loss wi~h respect to the surgeon in charge are dIsplayed m Table 3 .
There was no significant difference in estimated blood loss between Group CS and Group NCS (P = 0.03), although there appeared to be a trend towards lower estimated blood loss in Group CS.
Only in the case of S3 was ther~ a significant differences between blood loss m Group CS (n = 19) and Group NCS (n = 24) (P =:= 0.002). .
The postoperative details are dIsplayed m Table 4 .
One patient in Group CS died several hours postoperatively as a result of a ruptured pulmonary artery from her Swan-Ganz catheter. All other patients left hospital. DISCUSSION The concept of autotransfusion is not new. In 1886 Duncan reinfused a patient's own blood during a leg amputation. Hallet et al. in 1987 studied the effects of the use of an autotransfusion device in one hundred patients undergoing elective aneurysm repair or ilio-femoral bypass. They demonstrated a 7.5% decrease in bank blood usage in the autotransfuslOn . group. Moreover 68% of the autotransfusion ~oup required no bank blood compared to only 4% m the non-autotransfusion group. The mean postoperative haemoglobin concentra~io~ was similar in both groups and there was no sIgmficant coagulopathy, haemolysis or increased morbi~ity in the autotransfusion groUp. 7 Our findmgs confirm these beneficial findings.
Use of the cell saver should at least be no more hazardous than transfusion with bank blood. There are a number of constituents of salvaged blood that may be detrimental to the patient. These. include tissue debris, activated platelets and whIte cells, erythrocytic stroma, activated complement and clotting factors and white cell lysosomal contents (as measured by serum elas.tase .levels). The possible consequences of remfUSlOn of such substances are severe, involving disseminated intravascular coagulation, adult respiratory distress syndrome and multiple organ failure. 89 It is claimed that washing of salvaged blood, as occurs in the Electromedics system, removes these potentially harmful substances. 10 The lack of postoperative complications in our study would support this contention although specific assays for complement etc. were not performed. Washing also removes more than 97% of anticoagulant (in our case heparin).11 There does not appear to be any difference in red cell survival between washed salvaged cells and stored bank blood. 12 
·P<O.OI
At present the only preclusions to the use of the cell saver in aortic surgery are co-existing malignancy or intra-abdominal sepsis, although availability and personal preferences of surgeons and anaesthetists could be factors.
Estimated blood loss is calculated from the measured blood loss (weight of sponges + volume in sucker bottles in Group NCS or volume scavenged by the cell saver in Group CS) plus an amount determined by the anaesthetist to account for unmeasured loss. That there was a trend towards lower estimated blood loss in Group CS raises the possibilities of different patient selection or different surgical technique between the two groups; however, it could just be indicative of a largely subjective measurement technique. Despite the similarities between our two groups the differences in bank blood usage was striking. Of the cell saver group we saw that 55% received no bank blood whatsoever during their admission, compared with 3% in the no cell saver group. The general rule at our institution would be to transfuse postoperative aneurysm patients with haemoglobin concentrations of less than 10g%. The differences in transfusion requirements between the two The postoperative outcome was the same in both groups. There was not a lower haemoglobin concentration in the cell saver group. There was no difference in duration ofICV stay, patients were in similar condition on arrival in the ICV and there was no increase in renal impairment in the cell saver group (which may have indicated inadequate oxygen delivery). The death of one patient in Group CS due to pulmonary artery rupture was unrelated to the use of the cell saver.
The relative cost of this autotransfusion system compared to using only bank blood is of obvious interest. The current calculated cost to the community of one unit of bank blood is about $90 (B. Wiley, Red Cross Blood Bank, Sydney: personal communication). The disposable cost of the cell saver is $245 for each patient. As the difference in bank blood usage between the two groups was 3.3 units per patient (which represents a cost of about $300) the autotransfusion system compares favourably. The cost effectiveness of a similar system has been established elsewhere. 13 Although no major benefits to outcome could be detected, use of the cell saver has the potential advantages of decreased risk of transmission of blood-borne disease, mismatched transfusion and conserving previous bank blood. The potential disadvantages such as reinfusion of cellular debris, coagulopathy and decreased red cell survival seem not to have been a factor in our survey as demonstrated by parallel outcome in the two groups.
This study demonstrates that intraoperative use of the cell saver significantly reduces bank blood requirements in abdominal aortic surgery with no detriment to the patient. .
By the application of stricter transfusion criteria, the use of bank blood could probably be even further reduced.
